Digital pathology can be defined as image-based information for the analysis, management, and interpretation of information achieved from a digital slide. In the field of pathology digital pathology is emerging technology. In the modern technology, specimen samples containing slides are converted into digital images for easy view, storage, analysis, and management of data collected and this enables the virtual microscopy, technology that enables posting image and transmission throughout the network connected. Data rich image helps in maintenance of patient health records electronically, therefore helps to compile and distribute the information to build the central database.
Some of the major players in global digital pathology are:
Perkin Elmer, Inc. (U.S.), Olympus Corporation (Japan), AstraZeneca plc (Definiens AG) (U.K.), Sectra AB (Sweeden), GE Healthcare (U.K.), Inspirata Co. (U.S.), The Danaher Corporation (U.S.), Koninklijke Philips N.V (Netherlands), F. Hoffmann-La Roche AG (Ventana Medical Systems) (Switzerland), Digipath Co. (U.S.), Carl Zeiss AG (Germany), 3D-Histech Ltd. (Hungary), Yokogawa Electronic Corporation (Japan), Quorum Technologies Inc. (Canada) and Hamamatsu Photonics K.K. (Japan) to name a few.
No comments:
Post a Comment